Hsbc Holdings »

Caris Life Sciences shares owned by Hsbc Holdings

Quarter-by-quarter ownership of Caris Life Sciences (CAI) shares owned by Hsbc Holdings from 13F filings

Historical chart of Hsbc Holdings investment in Caris Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Caris Life Sciences held by Hsbc Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caris Life Sciences by Hsbc Holdings

Quarter filed Position value Share count Share price at filing
2026-03-31 $295k 17k 17.88
2025-12-31 $259k 9.6k 26.98

More positions owned by Hsbc Holdings

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
UnitedHealth (UNH)
Micron Technology (MU)
Johnson & Johnson (JNJ)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)

View all positions for Hsbc Holdings

Top funds holding Caris Life Sciences

Sixth Street Partners Management Company
J. H. Whitney Equity Partners VI
FMR
Coatue Management
T. Rowe Price Investment Management
Braidwell
PointState Capital
BlackRock
Neuberger Berman Group
Vanguard Portfolio Management
Vanguard Capital Management
OrbiMed Advisors
UBS Group
Thomas Stevens, CFA"
Duquesne Family Office

View all funds holding Caris Life Sciences